Please take a moment to review the latest ASCO News
- Interventions Needed to Improve Data Collection on Sexual Orientation and Gender Identity in Oncology Practice, Survey Finds
- Leading National Cancer Organizations Release Wide-ranging Recommendations to Expand Diverse Participation in Cancer Clinical Trials
- Watch ASCO CEO Dr. Clifford A. Hudis Speak About Cancer Health Equity and Disparities on Expert Panel
- Prior Authorization Causes Significant Care Delays in Medicare Advantage, Federal Agency Report Says
- Provider Relief Fund: May 13 Deadline to Request Late Reporting for Period 2
- Proposed FDA User Fee Agreement Packages Include Several ASCO Priorities for FDA
- Proposed FDA User Fee Agreement Package Would Strengthen Accelerated Approvals, Increase Diversity of Clinical Trials
- Beneficiary Protections, Efforts to Reduce Disparities Finalized in Medicare Advantage and Part D
- FDA Proposes Ban on Menthol Cigarettes and Flavored Cigars
- ASCO’s CancerLinQ® and Atropos Health Collaborate to Harness Real-World Data to Provide Point-of-Care Informatics Consult to Oncologists
- ASCO Expands Oncology Summer Internship Program with Aims to Increase Workforce Diversity
- 2023 ACA Rule Finalizes Health Insurance Market Changes, Aims for Equitable Access to Coverage
- 2021 MIPS Cost Performance Category Reweighted to 0% for Groups and Individuals
- Urge Congress to Provide More Funding for Cancer Research in Fiscal Year 2023
- Provider Recommendations on Diet, Exercise Positively Impact Patient Behavior